Skip to main content
Erschienen in: Intensive Care Medicine 6/2010

01.06.2010 | Brief Report

Iatrogenic events contributing to ICU admission: a prospective study

verfasst von: Emmanuelle Mercier, Bruno Giraudeau, Guy Giniès, Dominique Perrotin, Pierre-François Dequin

Erschienen in: Intensive Care Medicine | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Objective

To determine the incidence, risk factors, severity, and preventability of iatrogenic events (IEs) as a cause of intensive care unit (ICU) admission.

Design

Comparison of patients admitted or not for IE. IE was diagnosed after assessing independently predefined criteria.

Setting

The ICU of a teaching hospital.

Patients

All patients consecutively admitted over 6 months.

Interventions

None.

Measurements and results

Characteristics of patients, supportive treatments, length of stay, and outcomes were recorded. For patients admitted for IE, cause, origin, and preventability of IE were assessed by consensus. Of 528 patients, 103 (19.5%) were admitted for IE. Their Simplified Acute Physiology Score (SAPS) II was higher (41.2 ± 22.6 versus 31.4 ± 18.6), as was their Logistic Organ Dysfunction (LOD) score. Surgical admissions and admission for shock were more frequent. The main risk factors were age, underlying disease, low Mac Cabe or Knaus score, number of physicians treating the patient, number of drugs prescribed, and other hospitalization within 1 month. Length of stay was higher (11.1 days versus 7.9 days, 0.5–6.0, p = 0.02). Catecholamine drugs, blood transfusion, and parenteral nutrition were more frequently required in the IE group. ICU mortality was 15.5% in the IE group and 11.3% in the group without IEs [not significant (ns) after adjustment]. IE was considered as probably preventable in 73.8% of cases.

Conclusion

Of admissions to the ICU, 19.5% resulted from IE, with high proportion of shock, leading to greater need for invasive treatments and longer stay in the ICU. Most cases of IE seemed preventable.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Trunet P, Le Gall JR, Lhoste F, Regnier B, Saillard Y, Carlet J, Rapin M (1980) The role of iatrogenic disease in admission to intensive care. JAMA 244:2617–2620CrossRefPubMed Trunet P, Le Gall JR, Lhoste F, Regnier B, Saillard Y, Carlet J, Rapin M (1980) The role of iatrogenic disease in admission to intensive care. JAMA 244:2617–2620CrossRefPubMed
2.
Zurück zum Zitat Laksmanan MC, Hershey CO, Breslau D (1986) Hospital admissions caused by iatrogenic disease. Arch Intern Med 146:1931–1934CrossRef Laksmanan MC, Hershey CO, Breslau D (1986) Hospital admissions caused by iatrogenic disease. Arch Intern Med 146:1931–1934CrossRef
3.
Zurück zum Zitat Brenan TA, Leape LL, Laird NM, Hebert L, Localio R, Lawthers AG, Newhouse JP, Weiler PC, Hiatt HH (1991) Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N Engl J Med 324:370–376 Brenan TA, Leape LL, Laird NM, Hebert L, Localio R, Lawthers AG, Newhouse JP, Weiler PC, Hiatt HH (1991) Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N Engl J Med 324:370–376
4.
Zurück zum Zitat Bates DW (1995) Incidence of adverse drug events and potential adverse drug events. Implications for prevention. JAMA 274:29–34CrossRefPubMed Bates DW (1995) Incidence of adverse drug events and potential adverse drug events. Implications for prevention. JAMA 274:29–34CrossRefPubMed
5.
Zurück zum Zitat Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: analysis of prospective studies. JAMA 279:1200–1205CrossRefPubMed Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: analysis of prospective studies. JAMA 279:1200–1205CrossRefPubMed
6.
Zurück zum Zitat Pouyanne P, Haramburu F, Imbs JL, Bégaud B (2000) Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. BMJ 320:1036CrossRefPubMed Pouyanne P, Haramburu F, Imbs JL, Bégaud B (2000) Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. BMJ 320:1036CrossRefPubMed
7.
Zurück zum Zitat Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP (1997) Adverse drug events in hospitalized patients. Excess length of stay, and attributable mortality. JAMA 277:301–306CrossRefPubMed Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP (1997) Adverse drug events in hospitalized patients. Excess length of stay, and attributable mortality. JAMA 277:301–306CrossRefPubMed
8.
Zurück zum Zitat Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, Small SD, Sweitzer BJ, Leape LL (1997) The costs of adverse drug events in hospitalized patients. JAMA 277:307–311CrossRefPubMed Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, Small SD, Sweitzer BJ, Leape LL (1997) The costs of adverse drug events in hospitalized patients. JAMA 277:307–311CrossRefPubMed
9.
Zurück zum Zitat Darchy B, Le Miere E, Figueredo B, Bavoux E, Domart Y (1999) Iatrogenic diseases as a reason for admission to the intensive care unit: incidence, causes, and consequences. Arch Intern Med 159:71–78CrossRefPubMed Darchy B, Le Miere E, Figueredo B, Bavoux E, Domart Y (1999) Iatrogenic diseases as a reason for admission to the intensive care unit: incidence, causes, and consequences. Arch Intern Med 159:71–78CrossRefPubMed
10.
Zurück zum Zitat Lehman LS, Puopolo AL, Shaykevich S, Brennan TA (2005) Iatrogenic events resulting in intensive care admission: frequency, cause, and disclosure to patients and institutions. Am J Med 118:409–413CrossRef Lehman LS, Puopolo AL, Shaykevich S, Brennan TA (2005) Iatrogenic events resulting in intensive care admission: frequency, cause, and disclosure to patients and institutions. Am J Med 118:409–413CrossRef
11.
Zurück zum Zitat Grenouillet-Delacre M, Verdoux H, Moore N, Haramburu F, Miremont-Salamé G, Etienne G, Robinson P, Gruson D, Hilbert G, Gabinski C, Bégaud B, Molimard M (2007) Life-threatening adverse drug reactions at admission to medical intensive care: a prospective study in a teaching hospital. Intensive Care Med 33:2150–2157CrossRefPubMed Grenouillet-Delacre M, Verdoux H, Moore N, Haramburu F, Miremont-Salamé G, Etienne G, Robinson P, Gruson D, Hilbert G, Gabinski C, Bégaud B, Molimard M (2007) Life-threatening adverse drug reactions at admission to medical intensive care: a prospective study in a teaching hospital. Intensive Care Med 33:2150–2157CrossRefPubMed
12.
13.
Zurück zum Zitat Edwards IR, Aronson JK (2000) Adverse drug reactions: definitions, diagnosis, and management. Lancet 356:1255–1259CrossRefPubMed Edwards IR, Aronson JK (2000) Adverse drug reactions: definitions, diagnosis, and management. Lancet 356:1255–1259CrossRefPubMed
14.
Zurück zum Zitat Mac Cabe WR, Jackson GG (1962) Gram negative bacteremia, etiology and ecology. Arch Intern Med 110:845 Mac Cabe WR, Jackson GG (1962) Gram negative bacteremia, etiology and ecology. Arch Intern Med 110:845
15.
Zurück zum Zitat Knaus WA, Zimmerman JE, Wagner DP, Draper EA, Lawrence DE (1981) APACHE, acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med 9:591–597PubMedCrossRef Knaus WA, Zimmerman JE, Wagner DP, Draper EA, Lawrence DE (1981) APACHE, acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med 9:591–597PubMedCrossRef
16.
Zurück zum Zitat Le Gall JR, Lemeshow S, Saulnier F (1993) New Simplified Acute Physiology Score (SAPS II) based on European/North American Multicenter Study. JAMA 270:2957–2963CrossRefPubMed Le Gall JR, Lemeshow S, Saulnier F (1993) New Simplified Acute Physiology Score (SAPS II) based on European/North American Multicenter Study. JAMA 270:2957–2963CrossRefPubMed
17.
Zurück zum Zitat Le Gall JR, Klar J, Lemeshow S, Saulnier F, Alberti C, Artigas A, Teres D (1996) The logistic Organ Dysfunction System. A new way to assess organ dysfunction in the intensive care unit. JAMA 276:802–810CrossRefPubMed Le Gall JR, Klar J, Lemeshow S, Saulnier F, Alberti C, Artigas A, Teres D (1996) The logistic Organ Dysfunction System. A new way to assess organ dysfunction in the intensive care unit. JAMA 276:802–810CrossRefPubMed
18.
Zurück zum Zitat Laepe LL, Brennan TA, Laird NM, Lawthers AG, Localio AR, Barnes BA, Hebert L, Newhouse JP, Weiler PC, Hiatt H (1991) The nature of adverse events in hospitalized patients, results of the Harvard Medical Practice Study II. New Engl J Med 324:370–384CrossRef Laepe LL, Brennan TA, Laird NM, Lawthers AG, Localio AR, Barnes BA, Hebert L, Newhouse JP, Weiler PC, Hiatt H (1991) The nature of adverse events in hospitalized patients, results of the Harvard Medical Practice Study II. New Engl J Med 324:370–384CrossRef
19.
Zurück zum Zitat Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, Cadoret C, Fish LS, Garber L, Kelleher M, Bates DW (2003) Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 289:1107–1116CrossRefPubMed Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, Cadoret C, Fish LS, Garber L, Kelleher M, Bates DW (2003) Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 289:1107–1116CrossRefPubMed
20.
Zurück zum Zitat Hammerman H, Kapeliovich M (2000) Drug-related cardiac iatrogenic illness as a cause for admission to the intensive cardiac care unit. Isr Med Assoc J 2:605–606 Hammerman H, Kapeliovich M (2000) Drug-related cardiac iatrogenic illness as a cause for admission to the intensive cardiac care unit. Isr Med Assoc J 2:605–606
21.
Zurück zum Zitat Classen DC, Pestotnik SL, Evans RS, Burke JP (1991) Computerized surveillance of adverse drug events in hospital patients. JAMA 266:2847–2851CrossRefPubMed Classen DC, Pestotnik SL, Evans RS, Burke JP (1991) Computerized surveillance of adverse drug events in hospital patients. JAMA 266:2847–2851CrossRefPubMed
Metadaten
Titel
Iatrogenic events contributing to ICU admission: a prospective study
verfasst von
Emmanuelle Mercier
Bruno Giraudeau
Guy Giniès
Dominique Perrotin
Pierre-François Dequin
Publikationsdatum
01.06.2010
Verlag
Springer-Verlag
Erschienen in
Intensive Care Medicine / Ausgabe 6/2010
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-010-1793-9

Weitere Artikel der Ausgabe 6/2010

Intensive Care Medicine 6/2010 Zur Ausgabe

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.